ACE and coronary artery disorder: There wre no significant differences between the statin treated and untreated groups regarding demographic characteristics, CHD risk factors at baseline (Table 1) and concomitant drug treatment (especially in angiotensin converting enzyme inhibitors or calcium channel blockers that might influence eGFR) (Table 3).